Hypermarcas (OTCMKTS:HYPMY) Short Interest Up 12,687.5% in June

Hypermarcas (OTCMKTS:HYPMY) was the recipient of a significant increase in short interest in June. As of June 30th, there was short interest totaling 2,046 shares, an increase of 12,687.5% from the June 15th total of 16 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average trading volume of 33,339 shares, the days-to-cover ratio is presently 0.1 days.

Hypermarcas Stock Performance

OTCMKTS HYPMY traded up $0.13 during trading on Friday, reaching $4.09. 2,969 shares of the company’s stock were exchanged, compared to its average volume of 24,426. The company has a 50 day moving average price of $4.28 and a two-hundred day moving average price of $4.39. The stock has a market cap of $2.88 billion, a P/E ratio of 8.52 and a beta of 0.71. Hypermarcas has a 1 year low of $3.71 and a 1 year high of $5.50.

Hypermarcas (OTCMKTS:HYPMY) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.10 EPS for the quarter. The business had revenue of $383.13 million for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%. Research analysts forecast that Hypermarcas will post 0.53 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, Zacks Research upgraded shares of Hypermarcas to a “hold” rating in a report on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, Hypermarcas presently has an average rating of “Buy”.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.